Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Deafness-small bowel diverticulosis-neuropathy syndrome is characterized by progressive sensorineural deafness, progressive sensory neuropathy and gastrointestinal abnormalities (progressive loss of gastric motility, small bowel diverticulosis).
Features include very common findings: Inner ear hearing loss (sensorineural hearing impairment), Malabsorption, Chronic diarrhea, and Hemiplegia and others; and common findings: Ptosis, Abnormality of the pharynx, Hyporeflexia, and Abnormal speech pattern. 22 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Peripheral neuropathy, Hemiplegia, Hyporeflexia |
Biomarker and diagnostic research for deafness-small bowel diverticulosis-neuropathy syndrome has been reported in the published literature.
Phenotype severity distribution: 8 very common features, 4 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for deafness-small bowel diverticulosis-neuropathy syndrome.
200 publications have been identified in PubMed for deafness-small bowel diverticulosis-neuropathy syndrome. Kisho has analyzed 130 by research type. Research spans Review / Meta-Analysis (41%), Basic Science / Preclinical (37%), and Clinical Trial Publication (10%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 53 | 41% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 8:43 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Digestive system |
3 |
Fat malabsorption, Malabsorption, Chronic diarrhea |
Eyes | 2 | Ptosis, Abnormal eye movements (abnormality of eye movement) |
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
Heart and blood vessels | 1 | Tachycardia |
Lab test results | 1 | Abnormal electrical muscle activity (EMG) (emg abnormality) |
Growth and development | 1 | Cachexia |
Skin | 1 | Cutaneous photosensitivity |
Laboratory research |
48 |
37% |
Clinical study results | 13 | 10% |
Disease patterns and progression | 11 | 8% |
New treatment approaches | 4 | 3% |
Testing and diagnosis research | 1 | 1% |
Ammann M (2026). [PMID: 41042466](https://pubmed.ncbi.nlm.nih.gov/41042466/). *Ann Surg Oncol*. [Clinical Trial Publication]
Deraison C (2026). [PMID: 41116050](https://pubmed.ncbi.nlm.nih.gov/41116050/). *Nat Rev Gastroenterol Hepatol*. [Review / Meta-Analysis]
DiBaise JK (2026). [PMID: 41823888](https://pubmed.ncbi.nlm.nih.gov/41823888/). *Expert Rev Gastroenterol Hepatol*. [Review / Meta-Analysis]
Kim A (2026). [PMID: 41790074](https://pubmed.ncbi.nlm.nih.gov/41790074/). *Gastroenterology*. [Basic Science / Preclinical]
Endo R (2026). [PMID: 41468887](https://pubmed.ncbi.nlm.nih.gov/41468887/). *Cell Stem Cell*. [Basic Science / Preclinical]
Khoi HH (2026). [PMID: 41652918](https://pubmed.ncbi.nlm.nih.gov/41652918/). *J Paediatr Child Health*. [Gene Therapy / Novel Therapeutics]
Buel KL (2026). [PMID: 41569910](https://pubmed.ncbi.nlm.nih.gov/41569910/). *FP Essent*. [Review / Meta-Analysis]
Gao J (2026). [PMID: 40749856](https://pubmed.ncbi.nlm.nih.gov/40749856/). *Gastroenterology*. [Clinical Trial Publication]
Scharf MW (2025). [PMID: 40810534](https://pubmed.ncbi.nlm.nih.gov/40810534/). *Gut Microbes*. [Clinical Trial Publication]
Escoda T (2025). [PMID: 39237384](https://pubmed.ncbi.nlm.nih.gov/39237384/). *Rev Med Interne*. [Review / Meta-Analysis]